Conclusion
Dapsone 5% gel is a novel option in Canada for treating acne vulgaris that may be operating via anti-inflammatory mechanisms. Efficacy in acne has been demonstrated in phase 3 and long-term studies. It has undergone rigorous evaluation for safety with no evidence of increased hemolytic risk even in G6PD-deficient patients.
Skin Therapy Letter. 2012;17(8):1-3. © 2012 SkinCareGuide.com